BioSpecifics Reports Second Quarter 2020 Financial and Operating Results
- Monday, August 10, 2020, 7:04
- Finance
- Add a comment
WILMINGTON, Del., Aug. 10, 2020 /PRNewswire/ — BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first-in-class collagenase-based product marketed as XIAFLEX® in North America, today…
About the Author
adminasapcorp has written 41558 stories on this site.